Targeting p62 as a More Optimal Approach to Inhibit Autophagy Using Verteporfin as a Repurposed Therapeutic in Prostate Cancer

Pharmacology, Toxicology and Pharmaceutical Science

1. Verteporfin 100%
2. Prostate Cancer 100%
3. Cancer Growth 54%
4. Transcription Factor Nrf2 45%
5. Carcinogenesis 27%
6. Docetaxel 27%
7. Hydroxychloroquine 27%
8. Tumor Resistance 18%
9. Tumor Growth 18%
10. Drug Resistance 9%
11. Macular Degeneration 9%
12. Genetically Engineered Mouse Strain 9%
13. Clinical Trial Design 9%
14. Abiraterone 9%
15. Mouse Model 9%
16. Androgen Receptor 9%
17. Combination Therapy 9%
18. Androgen 9%
19. Prostate Tumor 9%
20. Cancer Survival 9%
21. Oligomer 9%